Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye Proteins | 17 | 2021 | 197 | 5.110 |
Why?
|
| Membrane Proteins | 15 | 2021 | 468 | 3.900 |
Why?
|
| Mutation | 9 | 2021 | 821 | 2.150 |
Why?
|
| Fatty Acids, Unsaturated | 9 | 2019 | 65 | 1.890 |
Why?
|
| Macular Degeneration | 11 | 2022 | 79 | 1.790 |
Why?
|
| Retina | 11 | 2022 | 421 | 1.480 |
Why?
|
| Photoreceptor Cells, Vertebrate | 3 | 2020 | 62 | 1.390 |
Why?
|
| Docosahexaenoic Acids | 6 | 2022 | 91 | 1.300 |
Why?
|
| Fatty Acids | 4 | 2020 | 201 | 1.240 |
Why?
|
| Retinal Cone Photoreceptor Cells | 6 | 2020 | 115 | 1.050 |
Why?
|
| Retinal Rod Photoreceptor Cells | 6 | 2021 | 90 | 1.010 |
Why?
|
| Retinal Degeneration | 4 | 2022 | 141 | 0.960 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2021 | 26 | 0.880 |
Why?
|
| Retinal Diseases | 2 | 2021 | 45 | 0.770 |
Why?
|
| Animals | 33 | 2022 | 10069 | 0.740 |
Why?
|
| Hippocampus | 3 | 2022 | 187 | 0.690 |
Why?
|
| DNA | 4 | 2021 | 365 | 0.670 |
Why?
|
| Mice | 24 | 2022 | 4467 | 0.650 |
Why?
|
| Cell Physiological Phenomena | 1 | 2018 | 7 | 0.630 |
Why?
|
| Central Nervous System Diseases | 1 | 2018 | 12 | 0.620 |
Why?
|
| Mammals | 1 | 2018 | 46 | 0.610 |
Why?
|
| Seizures | 1 | 2017 | 46 | 0.580 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 39 | 0.500 |
Why?
|
| Rats | 9 | 2021 | 1544 | 0.480 |
Why?
|
| Acetyltransferases | 2 | 2011 | 36 | 0.470 |
Why?
|
| Disease Models, Animal | 9 | 2022 | 1405 | 0.460 |
Why?
|
| Rod Cell Outer Segment | 1 | 2014 | 42 | 0.450 |
Why?
|
| Hepatocytes | 1 | 2014 | 75 | 0.430 |
Why?
|
| Retinaldehyde | 2 | 2010 | 7 | 0.420 |
Why?
|
| Geographic Atrophy | 2 | 2022 | 5 | 0.400 |
Why?
|
| Mice, Transgenic | 4 | 2021 | 490 | 0.330 |
Why?
|
| Retinal Pigment Epithelium | 4 | 2022 | 90 | 0.290 |
Why?
|
| Electroretinography | 5 | 2020 | 173 | 0.250 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 90 | 0.240 |
Why?
|
| Humans | 14 | 2022 | 27143 | 0.230 |
Why?
|
| Rats, Transgenic | 2 | 2021 | 12 | 0.230 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 627 | 0.200 |
Why?
|
| Blotting, Western | 6 | 2021 | 506 | 0.200 |
Why?
|
| Iron Overload | 1 | 2022 | 3 | 0.200 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 68 | 0.200 |
Why?
|
| Oxidative Stress | 5 | 2022 | 630 | 0.190 |
Why?
|
| Astrocytes | 1 | 2022 | 73 | 0.190 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2021 | 22 | 0.190 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 455 | 0.180 |
Why?
|
| Receptors, Neuropeptide | 1 | 2021 | 4 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2021 | 49 | 0.180 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2021 | 18 | 0.180 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 26 | 0.180 |
Why?
|
| Night Vision | 1 | 2020 | 7 | 0.180 |
Why?
|
| Macula Lutea | 1 | 2020 | 5 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 2 | 2016 | 333 | 0.180 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 209 | 0.170 |
Why?
|
| Estradiol | 1 | 2020 | 174 | 0.170 |
Why?
|
| Longevity | 1 | 2020 | 129 | 0.160 |
Why?
|
| Sphingomyelins | 1 | 2019 | 11 | 0.160 |
Why?
|
| Semen | 1 | 2019 | 27 | 0.160 |
Why?
|
| Spermatozoa | 1 | 2019 | 32 | 0.160 |
Why?
|
| Glycerophospholipids | 1 | 2018 | 14 | 0.150 |
Why?
|
| Gene Expression | 3 | 2016 | 407 | 0.150 |
Why?
|
| Cell Line | 3 | 2010 | 679 | 0.150 |
Why?
|
| Phenotype | 1 | 2020 | 666 | 0.150 |
Why?
|
| Sequence Deletion | 1 | 2018 | 65 | 0.150 |
Why?
|
| Phosphatidylethanolamines | 1 | 2017 | 23 | 0.140 |
Why?
|
| Phosphatidylserines | 1 | 2017 | 20 | 0.140 |
Why?
|
| Genes, Dominant | 2 | 2014 | 35 | 0.140 |
Why?
|
| Apoptosis | 3 | 2016 | 738 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 41 | 0.140 |
Why?
|
| Endoplasmic Reticulum | 2 | 2014 | 77 | 0.140 |
Why?
|
| Theranostic Nanomedicine | 1 | 2016 | 22 | 0.130 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2016 | 6 | 0.130 |
Why?
|
| Memory Disorders | 1 | 2016 | 47 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2016 | 81 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2016 | 665 | 0.130 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2014 | 29 | 0.130 |
Why?
|
| Neurons | 1 | 2017 | 274 | 0.130 |
Why?
|
| Genetic Therapy | 1 | 2016 | 116 | 0.120 |
Why?
|
| Liposomes | 1 | 2016 | 142 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2016 | 110 | 0.120 |
Why?
|
| Fertility | 2 | 2019 | 58 | 0.120 |
Why?
|
| Arachidonic Acid | 2 | 2011 | 18 | 0.120 |
Why?
|
| Male | 9 | 2022 | 13017 | 0.120 |
Why?
|
| Diet | 1 | 2016 | 225 | 0.110 |
Why?
|
| Xenopus laevis | 1 | 2014 | 47 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 28 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 110 | 0.110 |
Why?
|
| Antioxidants | 2 | 2022 | 222 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2020 | 792 | 0.100 |
Why?
|
| Cell Communication | 1 | 2013 | 66 | 0.100 |
Why?
|
| Aging | 1 | 2020 | 960 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 134 | 0.100 |
Why?
|
| Tissue Distribution | 2 | 2010 | 132 | 0.100 |
Why?
|
| Receptor, Insulin | 1 | 2013 | 93 | 0.100 |
Why?
|
| PC12 Cells | 1 | 2011 | 20 | 0.100 |
Why?
|
| Cells, Cultured | 4 | 2021 | 975 | 0.100 |
Why?
|
| Brain | 1 | 2017 | 708 | 0.090 |
Why?
|
| Transgenes | 2 | 2008 | 59 | 0.090 |
Why?
|
| Dietary Supplements | 2 | 2009 | 220 | 0.090 |
Why?
|
| Obesity | 1 | 2016 | 651 | 0.090 |
Why?
|
| Female | 7 | 2022 | 14634 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2010 | 150 | 0.080 |
Why?
|
| Light | 2 | 2008 | 117 | 0.080 |
Why?
|
| Linoleoyl-CoA Desaturase | 1 | 2009 | 2 | 0.080 |
Why?
|
| Spermatogenesis | 1 | 2009 | 11 | 0.080 |
Why?
|
| Lipid Peroxidation | 2 | 2022 | 47 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 131 | 0.080 |
Why?
|
| Molecular Structure | 1 | 2010 | 239 | 0.080 |
Why?
|
| Phytotherapy | 1 | 2008 | 23 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 195 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2010 | 236 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2008 | 60 | 0.080 |
Why?
|
| Curcumin | 1 | 2008 | 67 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2010 | 647 | 0.070 |
Why?
|
| Response Elements | 1 | 2007 | 21 | 0.070 |
Why?
|
| Thioredoxin-Disulfide Reductase | 1 | 2007 | 14 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2013 | 1374 | 0.070 |
Why?
|
| Cell Survival | 3 | 2016 | 394 | 0.070 |
Why?
|
| bcl-X Protein | 1 | 2006 | 34 | 0.070 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2006 | 32 | 0.070 |
Why?
|
| Rod Opsins | 1 | 2006 | 14 | 0.070 |
Why?
|
| Integrases | 1 | 2006 | 39 | 0.060 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2019 | 113 | 0.060 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2007 | 119 | 0.060 |
Why?
|
| Sperm Motility | 2 | 2019 | 14 | 0.060 |
Why?
|
| Sperm Count | 2 | 2019 | 17 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2022 | 1494 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2014 | 206 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2014 | 176 | 0.050 |
Why?
|
| Rats, Wistar | 2 | 2016 | 149 | 0.050 |
Why?
|
| Gliosis | 1 | 2022 | 17 | 0.050 |
Why?
|
| Herpesvirus 1, Human | 1 | 2002 | 24 | 0.050 |
Why?
|
| Serine | 1 | 2022 | 47 | 0.050 |
Why?
|
| Superoxides | 1 | 2022 | 60 | 0.050 |
Why?
|
| Interferon-beta | 1 | 2002 | 40 | 0.050 |
Why?
|
| Interferon-alpha | 1 | 2002 | 50 | 0.050 |
Why?
|
| Virus Replication | 1 | 2002 | 62 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 62 | 0.050 |
Why?
|
| Motor Disorders | 1 | 2021 | 9 | 0.050 |
Why?
|
| Rats, Long-Evans | 1 | 2021 | 34 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2021 | 15 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 55 | 0.050 |
Why?
|
| Hexokinase | 1 | 2021 | 16 | 0.050 |
Why?
|
| Cerebellum | 1 | 2021 | 41 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2014 | 101 | 0.050 |
Why?
|
| Hypothalamus | 1 | 2020 | 29 | 0.050 |
Why?
|
| Glycolysis | 1 | 2021 | 82 | 0.050 |
Why?
|
| Iron | 1 | 2022 | 107 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2016 | 538 | 0.050 |
Why?
|
| Sex Factors | 1 | 2022 | 451 | 0.040 |
Why?
|
| Bruch Membrane | 1 | 2020 | 2 | 0.040 |
Why?
|
| Lipofuscin | 1 | 2020 | 7 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2021 | 79 | 0.040 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2020 | 15 | 0.040 |
Why?
|
| Lipoproteins | 1 | 2020 | 95 | 0.040 |
Why?
|
| Semen Analysis | 1 | 2019 | 13 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 298 | 0.040 |
Why?
|
| Insulin Resistance | 1 | 2020 | 172 | 0.040 |
Why?
|
| Lipids | 1 | 2019 | 198 | 0.040 |
Why?
|
| Liver | 1 | 2020 | 424 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 129 | 0.040 |
Why?
|
| Thymocytes | 1 | 2016 | 12 | 0.030 |
Why?
|
| Retinal Ganglion Cells | 1 | 2016 | 26 | 0.030 |
Why?
|
| Intravitreal Injections | 1 | 2016 | 33 | 0.030 |
Why?
|
| Spatial Memory | 1 | 2016 | 15 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2016 | 13 | 0.030 |
Why?
|
| Paraquat | 1 | 2016 | 2 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2016 | 22 | 0.030 |
Why?
|
| Maze Learning | 1 | 2016 | 78 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 187 | 0.030 |
Why?
|
| Protective Agents | 1 | 2016 | 15 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2017 | 199 | 0.030 |
Why?
|
| Motor Activity | 1 | 2016 | 145 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 1939 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 509 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2014 | 54 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 69 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 77 | 0.030 |
Why?
|
| Histidine | 1 | 2014 | 50 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2014 | 102 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 129 | 0.030 |
Why?
|
| Protein Transport | 1 | 2014 | 153 | 0.030 |
Why?
|
| Microsomes | 1 | 2013 | 7 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2016 | 398 | 0.030 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2013 | 31 | 0.030 |
Why?
|
| Retinitis Pigmentosa | 1 | 2013 | 28 | 0.030 |
Why?
|
| Genotype | 1 | 2014 | 444 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2013 | 65 | 0.030 |
Why?
|
| Mitochondria | 1 | 2016 | 333 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 675 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2013 | 388 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 2629 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 2991 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 5223 | 0.020 |
Why?
|
| Cholestadienes | 1 | 2009 | 2 | 0.020 |
Why?
|
| Sperm Head | 1 | 2009 | 2 | 0.020 |
Why?
|
| Flagella | 1 | 2009 | 27 | 0.020 |
Why?
|
| Testis | 1 | 2009 | 35 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2009 | 58 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2008 | 24 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 86 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2008 | 187 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 6907 | 0.020 |
Why?
|
| Maf Transcription Factors, Small | 1 | 2007 | 1 | 0.020 |
Why?
|
| Genes, jun | 1 | 2007 | 3 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 50 | 0.020 |
Why?
|
| Oxidants | 1 | 2007 | 30 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2007 | 36 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 17 | 0.020 |
Why?
|
| Adult | 1 | 2019 | 7498 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 42 | 0.020 |
Why?
|
| Thioredoxins | 1 | 2007 | 26 | 0.020 |
Why?
|
| Aldehydes | 1 | 2007 | 55 | 0.020 |
Why?
|
| Photoreceptor Cells | 1 | 2007 | 36 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 65 | 0.020 |
Why?
|
| DNA Repair | 1 | 2007 | 82 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 438 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 138 | 0.020 |
Why?
|
| Retinal Bipolar Cells | 1 | 2006 | 6 | 0.020 |
Why?
|
| Mosaicism | 1 | 2006 | 12 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2007 | 240 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 264 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 61 | 0.020 |
Why?
|
| DNA Damage | 1 | 2007 | 147 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 399 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2002 | 29 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2002 | 62 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 312 | 0.010 |
Why?
|